Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The $840 billion startup’s ⁠wildly successful partnership with Microsoft contains a prenuptial agreement triggered when artificial general intelligence is achieved. Snag is, ‌the ⁠definition and its ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...